Satoru Murayama

Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: Comparison with apoprotein CIII

Tsutomu Hirano, Taro Sakaue, Asako Misaki et al. · Kidney International · 2003 · 57 citations · Full text

Metabolic Syndrome, Urology, Renal Disease +13

Safety, Tolerability and Pharmacokinetics of MCI-186 in Patients with Acute Ischemic Stroke: New Formulation and Dosing Regimen

Markku Kaste, Satoru Murayama, Gary A. Ford et al. · Cerebrovascular Diseases · 2013 · 56 citations

Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients

Ayako Ikejiri, Tsutomu Hirano, Satoru Murayama et al. · Metabolism · 2004 · 41 citations

Hemodialysis, Vascular Disease, Hemodialysis Patients +14

Low-Dose Candesartan Cilexetil Prevents Early Kidney Damage in Type 2 Diabetic Patients with Mildly Elevated Blood Pressure.

Satoru Murayama, Tsutomu Hirano, Taro Sakaue et al. · Hypertension Research · 2003 · 29 citations · Full text